2. Department of Cardiology, Cardiovascular Center Aalst OLV Hospital, Aalst, Belgium
3. Department of Cardiology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
4. The Heart Center, Rigs Hospital, University of Copenhagen, Copenhagen, Denmark
5. Department of Cardiology, Meir Medical Center, Kfar Saba, Israel
6. Department of Cardiology, St. Francis Hospital, Roslyn, NY
7. Columbia University Medical Center, New York, NY and Cardiovascular Research Foundation, New York, NY
8. Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel
9. Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA
10. Department of Cardiology, HaSharon Medical Center, Petach Tikva, Israel
11. Department of Cardiology, Shaare Zedek Medical Center, Jerusalem, Israel
12. Division of Cardiovascular Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
13. Cardiovascular Research Foundation, New York, NY
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.
Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.
To read the full content of this article, please log in to download the PDF.
Methods and results: FFRangio was measured in a blinded fashion in 301 patients (319 vessels) who were undergoing FFRwire assessment. Using an FFRwire ≤0.80 as a reference, the diagnostic performance of FFRangio was compared in pre-specified subgroups. The mean FFRwire and FFRangio were 0.81 ± 0.13 and 0.80 ± 0.12. Overall, FFRangio had a sensitivity of 93.5% and specificity of 91.2% for predicting FFRwire. Patient characteristics including age, sex, clinical presentation, body mass index, and diabetes did not affect sensitivity or specificity (p>0.05 for all). Similarly, lesion characteristics including calcification, tortuosity did not affect sensitivity or specificity (p>0.05 for all), nor did lesion location (proximal, middle, versus distal). Sensitivity was equally high across all target vessels, while specificity was highest in the LAD and lower (~85%) in the RCA and LCx (p<0.05).
Conclusions: FFRangio derived from coronary angiography has a high diagnostic performance regardless of patient and most lesion characteristics. The interaction of vessel on the specificity will need to be confirmed in larger cohorts.
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com